+Vote!
QJ.NET (Free subscription) | yesterday
So what really caused the delay for SCEE 's Wipeout HD ? Was it really because it failed an epilepsy test as some reports would have us believe? According to SCEE, "The reason for the delay of Wipeout HD on PS3 has been to to the many improvements we have been making and the numerous features we've added to the game." Improvements and features, huh? Yep, and they're actually exciting stuff. These...
+Vote!
Quilting and Patchwork (Free subscription) | 07/24/2008
QuiltingAndPatchwork.com In additon to the giveway on Quilting and Patchwork for the book What I Learned From God While Quilting, I have a giveaway on Alzheimer’s Notes. This giveaway for High Heels to Hormones (A Woman’s Guide to Spinal Care) was organized by my co-blogger, Liz Lewis. She also featured a guest post by author Christine Lasich, MD : [...]
+Vote!
Medical News Today (Free subscription) | 07/23/2008
Researchers at the National Institute of Standards and Technology (NIST) and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer's disease actually impairs a neuron's structure and function.
+Vote!
Curing Death by Curing Aging (Free subscription) | 07/22/2008
Genetic mechanisms at play in blood cells also control a gene and protein that cause Parkinson's disease.
+Vote!
Edinburgh Evening News (Free subscription) | 07/22/2008
EDINBURGH residents are being asked to help raise money in support of severe childhood epilepsy.
+Vote!
Physorg (Free subscription) | 07/21/2008
What does the genetics of blood cells have to do with brain cells related to Parkinson's disease? From an unusual collaboration of neurologists and a pharmacologist comes the surprising answer: Genetic mechanisms at play in blood cells also control a gene and protein that cause Parkinson's disease.
+Vote!
Business Wire (Free subscription) | 07/21/2008
PALO ALTO, Calif.--(BUSINESS WIRE)--Following successful work in the areas of diabetes, chronic pain, inflammation and neurological disorders, Frost & Sullivan is seeking partner
+Vote!
Nature (Free subscription) | 07/21/2008
Tuberous sclerosis complex (TSC) is caused by heterozygous mutations in the TSC 1 or TSC 2 genes and is characterized by a broad range of symptoms, such as mental retardation, seizures and behavioural problems. Ehninger et al. investigated hippocampus-dependent learning in
1Vote!
Pink Is The New Blog (Free subscription) | 07/20/2008
Jenny McCarthy and Jim Carrey played host at an event here in LA last night for Generation Rescue, a non-profit organization that was formed by parents of children who have been diagnosed with childhood neurological disorders (Autism, Asperger’s, ADHD, ADD, PDD-NOS and other learning disabilities). Jenny became involved with the organization after she discovered [...]
+Vote!
Medical News Today (Free subscription) | 07/19/2008
The Michael J. Fox Foundation for Parkinson's Research has announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five million Parkinson's patients worldwide.
+Vote!
Hindu (Free subscription) | 07/19/2008
MYSORE: Apollo BGS Hospital is conducting free camp for those suffering from neurological disorders on Monday at its Nanjangud clinic from 10 a.m. to 2 p.m, according to a press release from Anil Sangli, chief of the Department of Neurology, ...
+Vote!
SignalBlog (Free subscription) | 07/18/2008
Biotechnology company Medivation Inc. said Thursday that Alzheimer’s disease patient’s taking the experimental drug Dimebon showed a significant improvement after six months and continued to benefit from the drug up to a year. The study results, being published in the medical journal The Lancet, show that after six months, Dimebon-treated patients showed significant improvements in Alzheimer’s [...]...
+Vote!
Red Orbit (Free subscription) | 07/17/2008
NEW YORK, July 17 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative.
+Vote!
Medical News Today (Free subscription) | 07/16/2008
For suffers of neurological disorders such as Parkinson's disease daily trembling and shaking can be unbearable however, new UQ research could assist in helping patients regain control. A team of UQ researchers is using their skills from across a number of different disciplines to help improve the success rate of Deep Brain Stimulation (DBS) surgery.
+Vote!
HowStuffWorks: Daily Stuff Feed (Free subscription) | 07/15/2008
Take a close-up look at the theoretical applications of memory study, which may benefit victims of neurological disorders, such as Alzheimer's disease.
3Vote!
rockport | 07/09/2008
Hyderabad-based Suven Life Sciences will make presentations on its portfolio of new chemical entities (NCEs) in tackling Alzheimer’s disease at the upcoming International Conference on Alzheimer’s Disease (ICAD).
1Vote!
soulfullvibes | 07/05/2008
Sean Combs aka Diddy became the target of a confused Alzheimer’s Disease sufferer during a recent stay in a Beverly Hills hotel. The unnamed elderly man approached Diddy as if he was an old friend, and then lashed out at the rapper-turned-style guru.
+Vote!
nitesh | 05/31/2008
The market penetration for insomnia drugs has not reached saturation point. Opportunities remain. But with the introduction of several new products the market is set to see changes, but expansion. This expansion is based on increased general awareness physicians better comprehension of the significance of this disease and the positive role that a sleep medication prescription plays. At present time...
